EU: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in the EU

In 2021, after two years of growth, there was significant decline in the EU medicaments containing insulin market, when its value decreased by -40.1% to $X. Overall, consumption continues to indicate a abrupt decrease. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the EU

In value terms, medicaments containing insulin production skyrocketed to $X in 2021 estimated in export price. In general, production showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2016 when the production volume increased by 21% against the previous year. The level of production peaked at $X in 2017; however, from 2018 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in the EU

In 2021, the amount of medicaments containing insulin but not antibiotics exported in the European Union soared to X tons, picking up by 43% compared with the previous year. In general, exports, however, showed a abrupt slump. The pace of growth appeared the most rapid in 2014 when exports increased by 47% against the previous year. The volume of export peaked at X tons in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports, however, faced a abrupt downturn. The level of export peaked at $X in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

Exports by Country

Austria (X tons) and Belgium (X tons) were the largest exporters of medicaments containing insulin but not antibiotics in 2021, recording near 41% and 32% of total exports, respectively. It was distantly followed by Denmark (X tons), creating a 14% share of total exports. The Czech Republic (X tons), Slovakia (X tons), Ireland (X tons) and France (X tons) held a relatively small share of total exports.

From 2012 to 2021, the biggest increases were recorded for Ireland (with a CAGR of +135.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing insulin supplying countries in the European Union were Austria ($X), Belgium ($X) and the Czech Republic ($X), together accounting for 81% of total exports. France, Denmark, Slovakia and Ireland lagged somewhat behind, together accounting for a further 10%.

Ireland, with a CAGR of +138.5%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the European Union stood at $X per ton in 2021, growing by 42% against the previous year. Overall, the export price, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 an increase of 78%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+13.9%), while the other leaders experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports in the EU

In 2021, purchases abroad of medicaments containing insulin but not antibiotics decreased by -60.6% to X tons for the first time since 2018, thus ending a two-year rising trend. Overall, imports faced a abrupt setback. The pace of growth was the most pronounced in 2020 when imports increased by 582% against the previous year. Over the period under review, imports reached the peak figure at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports contracted notably to $X in 2021. Over the period under review, imports, however, continue to indicate a buoyant increase. The pace of growth was the most pronounced in 2020 when imports increased by 533%. As a result, imports reached the peak of $X, and then plummeted in the following year.

Imports by Country

The countries with the highest levels of medicaments containing insulin imports in 2021 were Denmark (X tons), together accounting for 98% of total import.

Denmark was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +27.5% from 2012 to 2021. While the share of Denmark (+97 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in the European Union.

From 2012 to 2021, the average annual growth rate of value in Denmark totaled +20.7%.

Import Prices by Country

In 2021, the import price in the European Union amounted to $X per ton, surging by 114% against the previous year. Over the period under review, the import price recorded a significant increase. The pace of growth appeared the most rapid in 2013 an increase of 186%. The level of import peaked in 2021 and is expected to retain growth in the immediate term.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to -5.3% per year.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :